Home Font Size: 1 2 3 Send to a Friend

News & Events

Eisai and Morphotek, Inc. Announce Initiation of MORAb-022 Study in Europe for the Treatment of Inflammatory Disease

June 28, 2010

...

+ Read the Article

Joye L. Bramble, PH.D. Appointed Vice President, Pilot Plant Operations for Morphotek, Inc.

May 18, 2010

...

+ Read the Article

Champions Biotechnology, Inc. and Morphotek®, Inc. Announce Agreement for an Oncology Evaluation Using Biomerk Tumorgraft™ Platform

April 19, 2010

Contact: Luigi Grasso, PhD - Morphotek®, Inc. 610-423-6100 info@morphotek.com Judee Shuler - Eisai Inc....

+ Read the Article

Morphotek, Inc. Breaks Ground for 60,000-Square-Foot Manufacturing Plant

March 8, 2010

...

+ Read the Article

Morphotek, Inc. Announces a Licensing Deal with Centocor Ortho Biotech Inc. for Exclusive Development and Commercialization Rights for a Therapeutic Monoclonal Antibody

October 28, 2009

...

+ Read the Article

Farletuzumab Data Presented on Phase II Clinical Trial in First-Relapsed Ovarian Cancer Subjects

September 24, 2009

...

+ Read the Article

Morphotek, Inc. Awarded Funding to Develop Therapeutic Antibodies Against Potential Biowarfare Toxins

September 23, 2009

...

+ Read the Article

Ovarian Cancer Patients Given True Gift of Happiness

August 25, 2009

...

+ Read the Article

Morphotek, Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies

July 15, 2009

...

+ Read the Article

Morphotek, Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease

July 1, 2009

...

+ Read the Article

Go to Page: 1 2 3 4 5 6 7 8 9 10

Results per page 10 25 50

©2005 Morphotek Inc. | 210 Welsh Pool Road | Exton, PA 19341 | (610) 423-6100 Privacy Policy | Site Map | Contact Us